1. Home
  2. SLNG vs GNLX Comparison

SLNG vs GNLX Comparison

Compare SLNG & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

N/A

Current Price

$3.81

Market Cap

97.4M

Sector

Utilities

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$1.88

Market Cap

110.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLNG
GNLX
Founded
2013
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.4M
110.4M
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
SLNG
GNLX
Price
$3.81
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $18.83
AVG Volume (30 Days)
18.4K
★ 429.6K
Earning Date
11-04-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.47
EPS
N/A
★ N/A
Revenue
★ $68,245,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$73.32
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.21
$1.77
52 Week High
$7.07
$5.89

Technical Indicators

Market Signals
Indicator
SLNG
GNLX
Relative Strength Index (RSI) 36.86 38.35
Support Level $3.69 $1.82
Resistance Level $4.44 $2.69
Average True Range (ATR) 0.30 0.17
MACD -0.00 -0.00
Stochastic Oscillator 43.65 16.00

Price Performance

Historical Comparison
SLNG
GNLX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. The company has a geographical presence in the United States and Mexico.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: